Bank of New York Mellon Corp - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 58 filers reported holding VIRACTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$20,163
+8.9%
12,6810.0%0.00%
Q4 2022$18,514
-65.7%
12,681
-0.4%
0.00%
Q3 2022$54,000
+10.2%
12,7270.0%0.00%
Q2 2022$49,000
-90.6%
12,727
-88.3%
0.00%
Q1 2022$520,000
+29.4%
109,215
-0.7%
0.00%
Q4 2021$402,000
-53.6%
110,013
+1.9%
0.00%
Q3 2021$866,000
-22.3%
107,938
+9.8%
0.00%
Q2 2021$1,115,00098,2950.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 689,709$374,9950.08%
Aisling Capital Management LP 288,571$156,8960.07%
BVF INC/IL 3,614,662$1,965,2920.06%
Planning Capital Management Corp 7,272$3,9540.00%
Laurion Capital Management LP 407,299$221,4480.00%
WealthTrust Axiom LLC 11,396$6,1960.00%
TRUST CO OF TOLEDO NA /OH/ 12,317$6,6970.00%
HoyleCohen, LLC 14,000$7,6120.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 74,000$40,2340.00%
INSPIRION WEALTH ADVISORS, LLC 15,000$8,1560.00%
View complete list of VIRACTA THERAPEUTICS INC shareholders